Chronic heart failure in adults
KEYWORDS: heart, failure, heart failure, chronic, chronic heart, adults, quality, data, statement, adults chronic, nice, specialist, care, cardiac, fraction

for side effects and symptoms of heart failure after each increase in dose. Commissioners (such as integrated care systems and NHS England) ensure that they commission services in which adults with chronic heart failure with reduced ejection fraction are prescribed appropriate medication. Adults with chronic heart failure with reduced ejection fraction (when the part of the heart that pumps blood around the body is not squeezing the blood as well as it should) are prescribed appropriate medications for heart failure. The medication is started and increased (when applicable) with check-ins for any changes in symptoms, side effects and, depending on the medication, based on input from their heart failure doctor. Source guidance • Chronic heart failure in adults: diagnosis and management. NICE guideline NG106 (2018, updated 2025), recommendations 1.4.1 to 1.4.4, 1.7.1 and 1.7.2 • Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction. NICE technology appraisal 388 (2016) recommendations 1.1 and 1.2 • Dapagliflozin for treating chronic heart failure with reduced ejection fraction. NICE technology appraisal guidance 679 (2021), recommendations 1.1 and 1.2 • Empagliflozin for treating chronic heart failure with reduced ejection fraction. NICE technology appraisal guidance 773 (2022), recommendations 1.1 and 1.2 Definitions of
